Menu

Sinovac Biotech, Ltd. SVA

Full chart Compare
Set alert

Price alert · SVA

All alert types
6.47 USD 0.00 (+0.00%)

At closeOct 28, 2026, 4:00 PM EDT

6.47 Day range 6.47
6.47 52-week range 6.47
YTD
0.00%
1 year
0.00%

Revenue & Expenses

Other Income → Expenses: $377.00MExpenses → Selling, General & Admin: $332.98MExpenses → Research & Development: $216.18MExpenses → Other Operating Expenses: $202.95MExpenses → Interest Expense: $9.82MIncome Tax Benefit → Expenses: $63.27MGross Profit → Expenses: $261.98MRevenue → Gross Profit: $261.98MRevenue → Cost of Revenue: $124.03MNet Loss → Expenses: $59.68MOther Income$377.00MIncome Tax Benefit$63.27MGross Profit$261.98MNet Loss$59.68MCost of Revenue$124.03MExpenses$761.93MSelling, General & Admin$332.98MResearch & Development$216.18MOther Operating Expenses$202.95MInterest Expense$9.82MRevenue$386.01M

Latest period ending Dec 31, 2025 · select a line to chart its full history

SVA annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
386.01M361.37M470.17M1.47B19.37B
261.98M220.69M323.32M815.24M18.38B
-490.13M-505.54M-713.98M-508.99M17.62B
-59.68M90.91M-13.49M14.47M8.12B
-0.831.27-0.190.20113.44
SVA annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
1.16B602.22M1.13B3.89B11.62B
8.54B12.34B13.61B14.03B16.76B
2.15B2.04B1.97B1.79B3.21B
505.62M391.32M298.98M74.67M144.91M
4.44B8.26B8.32B8.49B9.00B
SVA annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-512.18M-56.89M138.65M-798.12M15.32B
4.39B456.36M-2.70B-6.09B-2.98B
-3.43B-823.95M-88.55M-299.53M-1.91B
-48.51M-95.80M-156.11M-326.28M-704.83M
554.21M-526.90M-2.76B-7.73B10.57B